Patents by Inventor Silvio Rodriguez

Silvio Rodriguez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060233742
    Abstract: This invention is related to the Molecular Pharmacology field and especially to the development of peptides useful for treating epithelial tumors and mainly those associated to oncogenic types of HPVs. The main objective of this invention is to identify peptides whose structure permits to block the Casein Kinase II (CKII) phosphorylation domain by direct interaction with such a site. In the present invention it is shown eleven cyclic peptides with different aminoacid sequences which inhibit the CKII phosphorylation in vitro, exhibit cytotoxicity on HPV-16 transformed cells (CaSki) and also increase the sensitivity of these cells to the cytostatic effect of interferon (IFN). Furthermore, the invention relates to the use of these peptides conjugated or fused to other peptides and chemical compounds which penetrates into cells as well as with the use of both peptide and chemical mimetic molecules.
    Type: Application
    Filed: December 4, 2002
    Publication date: October 19, 2006
    Inventors: Silvio Rodriguez, Osvaldo Reyes Acosta, Nelson Santiago Vispo, Yaquelin Puchades Izaguirre, Ricardo Silva Rodriguez, Alejandro Moro Soria, Alicia Santos Savio, Luis González López, Belkis González Barrios
  • Publication number: 20060182713
    Abstract: Vaccine composition containing IL-15 for active immunization to treatment diseases related to over-expression of this cytokine. The technical aim pursued in this invention is to inhibit IL-15 activity through development of a therapeutic vaccine which elicits IL-15 neutralizing antibodies in the immunized host. IL-15 can be presented in this vaccine composition either alone or coupled to a carrier such as the P64k protein with a vaccine adjuvant such as Aluminum hydroxide. Besides, this invention is related to the use of this vaccine for treatment of Rheumatoid arthritis and other IL-15 over-expressing related diseases, and leukemia, where this cytokine acts as a growth factor.
    Type: Application
    Filed: October 8, 2003
    Publication date: August 17, 2006
    Inventors: Alicia Savio, Ricardo Rodriguez, Yanelis Diaz, Armando Rodriguez Alfonso, Jose Rafael Castillo, Haydee Perez, Alejandro Soria, Silvio Rodriguez
  • Patent number: 4340385
    Abstract: Compounds of the formula ##STR1## wherein R.sub.1 is C.sub.1-4 alkyl,R.sub.2 is hydrogen, C.sub.1-4 alkyl or C.sub.1-4 alkoxy,R.sub.3 is hydrogen or C.sub.1-4 alkyl, andM is hydrogen or a monovalent non-chromophoric cation,and mixtures of such compounds, stable, concentrated, aqueous compositions consisting essentially of, by weight,5-20% Compound of said formula in salt form or a mixture thereof2-25% 2-(2-Methoxyethoxy)ethanol0-8% Propylene glycolBalance Water,and the use of such compounds, mixtures and stable, concentrated, aqueous compositions for dyeing and printing anionically dyeable substrates such as natural and synthetic polyamides, especially nylon carpet.
    Type: Grant
    Filed: February 23, 1981
    Date of Patent: July 20, 1982
    Assignee: Sandoz, Inc.
    Inventors: Silvio A. Rodriguez, Sigmund C. Catino, deceased